turnaround ahead schedul strong increas confid reit ow rais pt
invest summari reiter overweight rate rais
price target deliv sale vs
factset consensu post better expect constant currenc growth
expect adjust ep beat consensu
print commentari repres anoth step forward complet full
turnaround america knee growth bp sequenti improv
tougher comp best growth last three year driven recent
launch product rosa knee cementless partial guidanc impli
acceler cc growth compar expect hit
wtd average market growth goal month earlier expect
strong knee drive top bottom line beat revenu
cc beat factset consensu organ growth acceler
sequenti quarter reflect broad strength across
busi knee growth best post
improv tougher comp driven rosa persona partial
cementless grew driven suppli stabil increas traction
special sale channel new product launch geograph apac
emea continu perform well grow respect
ep beat slightli higher gm om
expect
guidanc rais rais bottom end full-year revenu
guidanc state expect sequenti
improv everi product categori cc growth guidanc increas
midpoint increas full year fx headwind guidanc
impli growth cc also rais lower end ep
guidanc rais revenu
estim respect rais
ep estim
increas invest high growth area pivot toward offens
suppli recoveri qualiti remedi issu track complet
year end manag plan expand commerci infrastructur need
support full launch rosa knee increas robot well
enhanc sale special expect full year
om previous believ full launch
new knee product partial cementless revis rosa tka drive
top-lin acceler premium price potenti market share
 valuat pt base price-to-earnings ep estim
disclosur section may found page
sourc compani document factset cantor fitzgerald estim
exhibit comparison cantor estim
compani document factset cantor fitzgerald estim
inc million except per dilut inc million except per share current priorcurr priorp growth gener adminstr incom expens tax provis dilut share juli
price target base price-to-earnings multipl ep estim
may abl recaptur share lost meaning amount hip knee share
last two year histor share shift given year ten basi
point may abl recaptur share quickli lost
larg ou exposur subject addit risk deriv net sale
outsid zbh larg intern oper expos number addit risk
includ fx risk polit econom instabl unexpect chang foreign regulatori
requir foreign medic reimburs polici
cut effort healthcar purchas organ may materi advers effect
zbh financi result mani zbh custom form group purchas organ
effort contain cost failur respond cost-contain effort group purchas
organ could materi advers effect sale margin
fda could take addit action fda conduct recent inspect found
observ said on-track remedi plan address old new
observ anticip fda could potenti issu warn letter take
action could neg affect zbh oper
million except per share data
cost good sold
sell gener adminstr
interest expens incom
incom incom tax
net incom mi
sell gener adminstr
amort intang
sell gener adminstr
compani document cantor fitzgerald research
zimmer biomet headquart warsaw indiana found becam public compani august spun
bristol-my squibb june zimmer acquir biomet deal creat current zimmer biomet pure-
play orthoped compani knee revenu hip revenu make total compani sport medicin
extrem trauma spine dental sale
